NMDA depresses glutamatergic synaptic transmission in the striatum through the activation of adenosine A1 receptors: evidence from knockout mice.
about
Adenosine and the auditory system.The small-conductance calcium-activated potassium channel is a key modulator of firing and long-term depression in the dorsal striatum.Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction.Adenosine A(1) receptor: Functional receptor-receptor interactions in the brain.The GABAA receptor agonist muscimol induces an age- and region-dependent form of long-term depression in the mouse striatum.Induction of cannabinoid- and N-methyl-D-aspartate receptor-mediated long-term depression in the nucleus accumbens and dorsolateral striatum is region and age dependent.Ethanol inhibits excitatory neurotransmission in the nucleus accumbens of adolescent mice through GABAA and GABAB receptors.Long-term potentiation in the nucleus accumbens requires both NR2A- and NR2B-containing N-methyl-D-aspartate receptors.Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit.CIQ, a positive allosteric modulator of GluN2C/D-containing N-methyl-d-aspartate receptors, rescues striatal synaptic plasticity deficit in a mouse model of Parkinson's disease.GluN2D-containing NMDA receptors inhibit neurotransmission in the mouse striatum through a cholinergic mechanism: implication for Parkinson's disease.Ethanol disrupts the mechanisms of induction of long-term potentiation in the mouse nucleus accumbens.
P2860
Q30482911-9BD2A7B3-1CBA-4D2F-A61E-2F86D4643737Q30499665-188A1151-2DF1-4EDC-8E0E-FEBF58019BA2Q35487248-47CCED5C-728B-4B50-87E1-074615C35B06Q37135517-65D2FEC1-1389-49B5-AAFC-1BAB3EE434BCQ41748040-9DCAEB88-43FF-4013-A7DF-99E88E46CCD6Q41852040-8FCD0B9C-B043-42A4-A012-B42FAF5B2CB7Q45373716-EBB6B01E-911D-4CCC-A99E-825CA4BAF074Q46644707-9E430E01-A500-4347-8C9A-A75AB8F4A182Q47306135-5A9F43CE-8389-4278-B661-83F5E0F3568AQ47920457-7AC7EEA8-460E-4307-A6D4-5A50781E7871Q48362193-DA706A56-BBB2-4685-8F2E-169117364227Q48536490-2535E399-2446-42D8-AD1D-FAFDEB1E5FFE
P2860
NMDA depresses glutamatergic synaptic transmission in the striatum through the activation of adenosine A1 receptors: evidence from knockout mice.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
NMDA depresses glutamatergic s ...... : evidence from knockout mice.
@en
NMDA depresses glutamatergic s ...... : evidence from knockout mice.
@nl
type
label
NMDA depresses glutamatergic s ...... : evidence from knockout mice.
@en
NMDA depresses glutamatergic s ...... : evidence from knockout mice.
@nl
prefLabel
NMDA depresses glutamatergic s ...... : evidence from knockout mice.
@en
NMDA depresses glutamatergic s ...... : evidence from knockout mice.
@nl
P1433
P1476
NMDA depresses glutamatergic s ...... : evidence from knockout mice.
@en
P2093
Bertil B Fredholm
Sietske M Schotanus
P304
P356
10.1016/J.NEUROPHARM.2006.03.025
P577
2006-05-18T00:00:00Z